What is Immunome's total liabilities & equity?

Immunome (IMNM) reported total liabilities & equity of $619.79M in Q1 2026.

How has Immunome's total liabilities & equity changed year-over-year?

Immunome's total liabilities & equity increased by 80.9% year-over-year, from $342.69M to $619.79M.

What is the long-term trend for Immunome's total liabilities & equity?

Over 5 years (2020 to 2025), Immunome's total liabilities & equity has grown at a 72.7% compound annual growth rate (CAGR), from $44.53M to $683.19M.

What does total liabilities & equity mean?

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Immunome IMNM Total Liabilities & Equity

Total Liabilities & Equity at other companies

PfizerPFE

$207.62B-0.2%

Arcus BiosciencesRCUS

$997M-13.8%

Nuvation BioNUVB

$610.24M+23.9%

SELLAS Life Sciences Group, Inc.SLS

$114.18M+227%

ArriVent BioPharma, Inc.AVBP

$349.3M+62.1%

IDEAYA Biosciences, Inc.IDYA

$1.03B-6.4%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's total liabilities & equity?: Immunome (IMNM) reported total liabilities & equity of $619.79M in Q1 2026.
How has Immunome's total liabilities & equity changed year-over-year?: Immunome's total liabilities & equity increased by 80.9% year-over-year, from $342.69M to $619.79M.
What is the long-term trend for Immunome's total liabilities & equity?: Over 5 years (2020 to 2025), Immunome's total liabilities & equity has grown at a 72.7% compound annual growth rate (CAGR), from $44.53M to $683.19M.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.